The IFN-regulatory factors IRF1, IRF3, IRF5, and IRF7 modulate processes involved in the pathogenesis of systemic lupus and lupus nephritis, but the contribution of IRF4, which has multiple roles in innate and adaptive immunity, is unknown. To determine a putative pathogenic role of IRF4 in lupus, we crossed Irf4-deficient mice with autoimmune C57BL/6-(Fas)lpr mice. IRF4 deficiency associated with increased activation of antigen-presenting cells in C57BL/6-(Fas)lpr mice, resulting in a massive increase in plasma levels of TNF and IL-12p40, suggesting that IRF4 suppresses cytokine release in these mice. Nevertheless, IRF4 deficiency completely protected these mice from glomerulonephritis and lung disease. The mice were hypogammaglobulinemic and lacked antinuclear and anti-dsDNA autoantibodies, revealing the requirement of IRF4 for the maturation of plasma cells. As a consequence, Irf4-deficient C57BL/6-(Fas)lpr mice neither developed immune complex disease nor glomerular activation of complement. In addition, lack of IRF4 impaired the maturation of Th17 effector T cells and reduced plasma levels of IL-17 and IL-21, which are cytokines known to contribute to autoimmune tissue injury. In summary, IRF4 deficiency enhances systemic inflammation and the activation of antigen-presenting cells but also prevents the maturation of plasma cells and effector T cells. Because these adaptive immune effectors are essential for the evolution of lupus nephritis, we conclude that IRF4 promotes the development of lupus nephritis despite suppressing antigen-presenting cells.
Systemic autoimmunity in systemic lupus erythematosus (SLE) involves a polyclonal expansion of lymphocytes that are autoreactive to multiple nuclear autoantigens. This process can cause a broad spectrum of clinical manifestations ranging from mild fever, skin rashes, and arthralgia to severe inflammation of kidney, lungs, or brain. 1 The pathogenesis of SLE is based on variable combinations of genetic polymorphisms that promote loss of tolerance or tissue inflammation. 2, 3 For example, certain genes impair lymphocyte apoptosis and the clearance of dying cells via opsonization, phagocytosis, and digestion of self-DNA, which all increase the release of nuclear particles from secondary necrotic lymphocytes and expose them to the immune system. 4 Another group of susceptibility genes enhances the immune recognition of self nucleic acids by Toll-like receptors (TLRs) in dendritic cells (DCs), which increases the production of type I IFN 5, 6 and eventually the expansion of autoreactive lymphocytes. 7 A third class of genetic lupus risk factors affects tissue inflammation. 4 IFN-regulatory factors (IRFs) form a group of transcription factors that have the potential to contribute to all of the aforementioned pathomechanisms of SLE. IRF-1 is a proinflammatory transcription factor that triggers the expression of proinflammatory cytokines in tubular epithelial cells and immune cells in the postischemic kidney 8 as well as in mesangial cells during lupus nephritis of MRL-(Fas)lpr mice. 9 IRF3 and IRF7 mediate type I IFN production upon immune recognition of viral and endogenous nucleic acids in DCs, 10 including TLR7 signaling, which was shown to be an essential pathway in SLE. 7, [11] [12] [13] IRF5 is required for immune cell maturation and for TLR signaling, two mechanisms that contribute to SLE and lupus nephritis of Fc␥RIIBϪ/ϪYaa or Fc␥RIIBϪ/Ϫ mice 14 and in lupus secondary to pristane injection. 15 Unlike other IRFs, IRF4 is not regulated by IFNs and its expression is restricted to immune cells. 16 IRF4 has multiple regulatory functions in adaptive immunity. 16, 17 For example, IRF4 is required for the maturation of B and T cells, 18 plasma cell maturation and Ig isotype switching, 19 the ability of regulatory T cells to suppress Th2 responses, 20 and the induction of Th17 T cells. 21, 22 IRF4 also regulates innate immunity because it is required for M2 macrophage polarization. 23 IRF4 also serves as an inhibitor of TLR signaling via binding to MyD88, which impairs its interaction with IRF5 and other downstream signaling elements. 24 For example, Irf4-deficient mice develop an exaggerated postischemic inflammatory response aggravating ischemic acute renal failure, which depends on the oxidative stress-driven induction of IRF4 in intrarenal DCs. 25 As another example, bacterial products specifically induce IRF4 in DCs of the intestinal wall, a mechanism that protects mice from experimental colitis. 26 Hence, IRF4 suppresses innate immunity but fosters adaptive immunity. These ambivalent immunoregulatory roles are again unique among the members of the IRF family.
Given Figure 1B ). Next we determined the activation state of various DC subsets in spleens of 6-month-old mice by flow cytometry. IRF4 deficiency increased the total numbers of CD11c/CD4-positive DCs and CD4/CD8 double-negative CD11c DCs ( Figure 1C ). IRF4 was required to suppress DC activation because B6 lpr/Irf4Ϫ/Ϫ mice displayed higher numbers of CD40-positive CD11c DCs and MHCII-positive F4/80/CD11c DCs ( Figure 1D ). In addition, lack of IRF4 increased the numbers of CD11b/F4/80-positive macrophages in spleens; most of them were MHCII positive, indicating a classically activated (M1) macrophage phenotype ( Figure 1E ). Alternatively activated CD206-positive macrophages remained in a minor splenocyte population in 6-month-old B6 lpr/Irf4Ϫ/Ϫ mice ( Figure 1E ). Taken together, lack of IRF4 increases systemic cytokine production and the activation of antigen-presenting cells in B6 lpr mice, indicating an immunosuppressive role for IRF4 in these aspects of innate immunity.
Lack of IRF4 Prevents Lupus Nephritis in B6
lpr Mice
Next we questioned whether the aggravated systemic inflammation in B6 lpr/Irf4Ϫ/Ϫ mice is associated with an aggravation of lupus nephritis. At 6 months of age, B6 lpr mice developed diffuse proliferative glomerulonephritis that was associated with diffuse mesangial matrix expansion, mesangial cell proliferation, and occasional tuft adhesions (Figure 2 ). Tuft necrosis and crescent formation were absent. On immunostaining, diffuse proliferative glomerulonephritis was associated with extensive glomerular IgM and IgG deposits presenting in mesangial (IgG) and capillary (IgM/IgG) staining patterns (Figure 2) . lpr mice. The indices of lupus nephritis disease activity and chronicity were assessed by semiquantitative morphometry on PAS-stained renal sections from 6-month-old mice of both mouse strains as described in Concise Methods. Plasma creatinine levels were determined at the same age. Data represent mean Ϯ SEM from at least 12 mice per group.
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Staining for complement factor 9 showed mainly mesangial positivity (Figure 2 ), altogether indicating diffuse proliferative lupus-like immune complex glomerulonephritis as the renal manifestation of spontaneous autoimmunity in B6 lpr mice. Lack of IRF4 completely abrogated this phenotype because age-matched B6 lpr/Irf4Ϫ/Ϫ mice developed hardly any glomerular Ig and complement deposits or glomerular abnormalities as shown by light microscopy ( Figure 2 ). This was also evident by morphometrical assessment of the activity and chronicity index for lupus nephritis ( Figure 3 ). Some renal sections showed a slight increase in activated mesangial cells in B6 lpr/Irf4Ϫ/Ϫ mice, but this was not a consistent finding. Abnormalities of the vascular or tubulointerstitial compartment were absent in both mouse strains. Because of the moderate renal lesions, plasma creatinine levels were only mildly elevated in B6 lpr mice and there was a nonsignificant trend toward lower levels in B6 lpr/Irf4Ϫ/Ϫ mice ( Figure 3 ). Albuminuria was absent in both strains (not shown).
The abrogated lupus nephritis phenotype in B6
lpr/Irf4Ϫ/Ϫ mice was associated with lower mRNA expression levels of the proinflammatory chemokines CCL2, CCL5, CXCL2, and CXCL10 ( Figure 4A ), which correlated with a significant reduction of Mac2-positive glomerular macrophages ( Figure 4B ). Together, lack of IRF4 protects B6 lpr mice from lupus nephritis.
Lack of IRF4 Prevents Autoimmune Lung Disease in B6 lpr Mice
Autoimmune lung disease is another manifestation of SLE. At 6 months of age, B6 lpr mice displayed focal areas of peribronchial and perivascular lymphocyte infiltrates ( Figure 5 ). Such infiltrates were not detected in age-matched B6 lpr/Irf4Ϫ/Ϫ mice, indicating that lack of IRF4 protects B6 lpr mice not only from lupus nephritis but also from autoimmune lung disease.
IRF4 Is Required for the Production of Lupus Autoantibodies in B6 lpr Mice
Lupus nephritis is a manifestation of immune complex disease in systemic autoimmunity. Glomerular immune complex deposits can develop in situ when circulating autoantibodies bind to nuclear particles that have deposited along the glomerular capillaries. Alternatively, circulating immune complexes get deposited along the glomerular filtration barrier. 28 In any case, lupus autoantibodies represent an essential element in the pathogenesis of lupus nephritis; therefore, we next examined the effect of the Irf4 genotype on lupus autoantibody formation. At the age of 6 months, B6 lpr mice displayed significant hypergammaglobulinemia and antinuclear antibodies (ANAs) as well as autoantbodies specifically directed against doublestranded DNA (dsDNA) or the Smith antigen ( Figure 6 ). By contrast, IRF4-deficient B6 lpr mice had low serum IgG levels, and ANAs, dsDNA, and Smith autoantibodies were absent ( Figure 6 ). Thus, IRF4 is required for the production of lupus autoantibodies in B6 lpr mice. light chains to quantify plasma cells in 6-month-old B6 lpr and B6 lpr/Irf4Ϫ/Ϫ mice. Lack of IRF4 was associated with a drastic reduction of the absolute numbers of spleen plasma cells on flow cytometry ( Figure 7A ). By contrast, the total numbers of mature B cells were not affected by the Irf4 genotype, although a shift from follicular-to marginal-zone B cells was observed in B6 lpr/Irf4Ϫ/Ϫ versus B6 lpr mice ( Figure 7A ). The comparable numbers of mature B cells on flow cytometry were consistent with identical staining patterns for IgM-positive cells in mice of both genotypes ( Figure 7B ). We therefore conclude that lack of IRF4 abrogates lupus nephritis because B6 lpr/Irf4Ϫ/Ϫ mice are plasma cell deficient and no longer produce those autoantibodies that cause immune complex glomerulonephritis.
Lack of IRF4 Reduces
The various T cell subsets are essential regulators of autoimmune disease. Regulatory T cells suppress the expansion of autoreactive T cells and autoantigen-specific Th1 or Th17 effector T cells that promote inflammatory tissue injury. 29, 30 We therefore quantified T cell subsets in the spleens of 6-month-old B6 lpr and B6 lpr/Irf4Ϫ/Ϫ mice by flow cytometry. The total number of CD3-positive T cells was not affected by the Irf4 genotype, but CD8 T cells were slightly reduced and CD4/CD25/Foxp3-positive "regulatory" T cells were increased in B6 lpr/Irf4Ϫ/Ϫ versus B6 lpr mice ( Figure 8A ). We identified Th1 and Th17 CD4 T cells by intracellular staining for IFN␥ or IL-17, respectively, and found that lack of IRF4 substantially reduced both of these subsets in B6 lpr mice ( Figure 8B ). By contrast, IL-17 positivity in CD4/CD8 double-negative T cells was independent of the Irf4 genotype (not shown). Consistent with the latter finding, IL-17 and IL-21 were substantially reduced in the serum of 6-month-old B6 lpr/Irf4Ϫ/Ϫ mice ( Figure 8C ). Together, IRF4 deficiency impairs the maturation of Th1 and Th17 T cells as well as that of autoantibodyproducing plasma cells, which is associated with an abrogation of lupus nephritis in B6 lpr mice.
DISCUSSION
IRFs contribute to SLE and lupus nephritis in various ways. IRF1 acts as a nonredundant transcription factor that promotes the expression of many proinflammatory genes in immune and nonimmune cells. 8, 9 IRF3 and IRF7 mediate the expression of type I IFNs upon activation of innate viral nucleic acid sensors that, in lupus, can also be activated by endogenous nucleic acids and lupus autoantigens. 7, 12 IRF5 is required for immune cell maturation and for TLR signaling, two mechanisms that contribute to human SLE and lupus nephritis of Fc␥RIIBϪ/ϪYaa or Fc␥RIIBϪ/Ϫ mice. 14 Here we show that IRF4 contributes to SLE and lupus nephritis in a different manner. On one side, lpr/Irf4Ϫ/Ϫ (E) and B6 lpr wild-type mice (F) were bled at the end of the study to determine serum levels of IgG, IgM, anti-Smith, and anti-dsDNA autoantibodies by ELISA. (B) ANAs were detected by staining of Hep2 cells using plasma dilutions of 1:40 as described in Concise Methods. Note the homogenous nuclear staining pattern using plasma from B6 lpr mice that was not detectable with plasma from B6 lpr/Irf4Ϫ/Ϫ mice.
BASIC RESEARCH www.jasn.org IRF4 suppresses innate immune recognition and therefore IRF4 deficiency enhances the activation of antigen-presenting cells including the production of NFB-dependent proinflammatory cytokines. Although this process should enhance autoimmunity and autoimmune tissue inflammation, Irf4-deficient B6 lpr mice still remain protected from glomerulonephritis because IRF4 has a nonredundant role in the maturation of plasma cells and Th1 and Th17 effector T cells, which protects B6 lpr mice from the evolution of autoimmunity and immune complex disease.
We have recently shown that IRF4 potently suppresses the activation of DCs in postischemic kidneys, a process that limits local cytokine production and thereby prevents excessive renal pathology and acute renal failure. 25 This immunosuppressive effect of IRF4 is related to its inducible expression in DCs, which blocks the interaction of IRF5 with the TLR adaptor MyD88 and thereby suppresses the local expression of NFB-dependent proinflammatory cytokines during bacterial or sterile forms of inflammation. 24 Consistent with this concept, spleen DCs and macrophages in Irf4-deficient B6 lpr mice were more activated and produced more proinflammatory cytokines as compared with their wild-type B6 lpr counterparts. IRF4-deficient splenocytes also showed increased IFN-␥ production by natural killer (NK)1.1 cells, whereas IRF4 deficiency did not affect IFN-␥ producing T cells. 31 This process should be sufficient to enhance autoimmunity and autoimmune tissue injury because enhanced antigen-presentation and co-stimulation is usually sufficient to increase the expansion of autoreactive B and T cells in lupus. 32 For example, lack of the TLR signaling inhibitor single immunglobulin IL-1R-related molecule was similarly associated with activated DCs and increased production of lupus autoantibodies and subsequent immune complex glomerulonephritis in B6 lpr mice. 33 In addition, we recently observed the same for IL-1 receptorassociated kinase M, a factor that suppresses TLR signaling in DCs at the kinase level (unpublished observation). However, increased activation of antigen-presenting cells and massively increased serum cytokine levels were not associated with more autoimmunity or more severe lupus nephritis in B6 lpr/Irf4Ϫ/Ϫ mice, most likely because of the lack of autoimmunity and immune complex disease.
The lack of lupus-like autoimmunity as indicated by the absence of ANAs and other lupus autoantibodies was the most prominent phenotype of B6 lpr/Irf4Ϫ/Ϫ mice. Our analysis identified an almost complete absence of plasma cells, which was also illustrated by hypogammaglobulinemia. IRF4 has a nonredundant role in plasma cell maturation and Ig class switch recombination while germinal center B cell formation remains intact. 19 As such, Irf4-deficient mice are generally unable to induce humoral immune responses to antigen exposure, 18 which obviously includes the production of ANAs in experimental lupus. These data document that innate immune activation is necessary but not sufficient to cause lupus nephritis because autoantibody-mediated immune complex disease is an essential com- ponent for the development of lupus nephritis. B6 lpr/Irf4Ϫ/Ϫ mice also lacked IFN␥-producing Th1 T cells and IL-17-producing Th17 T cells, both of which have been shown to contribute to glomerulonephritis 30 and lupus nephritis in lpr mutant lupus mice. 34, 35 IRF4 is required for the maturation of T cells, 18, 31 especially for T cell priming toward Th17 cells, because IRF4 phosphorylation by ROCK2 is required for the synthesis of IL-17 and of IL-21. 21 As such, B6
lpr/Irf4Ϫ/Ϫ mice lack the major effector T cell populations that are involved in autoimmune tissue injuries including lupus nephritis beyond the production of lupus autoantibodies by plasma cells.
In summary, IRF4 has nonredundant biologic effects for evolution of immune complex glomerulonephritis like the other members of the IRF family, namely IRF1, IRF3, IRF5, and IRF7. However, the mechanisms by which IRF4 contributes to autoimmune tissue injury differ from those of the other IRF family members. Although IRF4 deficiency activates antigen-presenting cells and induces systemic inflammation, lack of IRF4 also severely impairs plasma cell maturation and subsequent autoantibody production as well as the maturation of Th1 and Th17 effector T cells. As a consequence, IRF4 deficiency protects from the evolution of autoimmunity and lupus-like immune complex glomerulonephritis. It is therefore very likely that these immunoregulatory roles of IRF4 contribute to other lupus disease models in a similar manner. Together, we conclude that IRF4 is essential for the development of lupus-like autoimmunity and immune complex glomerulonephritis despite its suppressive effect on innate immunity.
CONCISE METHODS

Animal Studies
Irf4-deficient mice were generated, genotyped, and backcrossed to the C57BL/6J strain for ten generations as described previously. 18 
B6
Irf4Ϫ/Ϫ and B6 lpr mice (Charles River) were mated to generate B6
lpr/Irf4Ϫ/ϩ mice, which were then mated among each other to generate B6 lpr/Irf4ϩ/ϩ and B6 lpr/Irf4Ϫ/Ϫ mice as described. 33 Littermate females were used for all experimental procedures. In each individual mouse, the genotype was assured by PCR. Mice were housed in groups of five mice in sterile filter-top cages with a 12-hour dark/ light cycle and unlimited access to autoclaved food and water. One cohort of mice was sacrificed at 24 weeks of age and one cohort was followed until 52 weeks of age. All experimental procedures were performed according to the German animal care and ethics legislation and were approved by the local governmental authorities. BASIC RESEARCH www.jasn.org
Flow Cytometry
Anti-mouse CD3, CD4, CD8, and CD25 antibodies (BD Pharmingen, Heidelberg, Germany) were used to detect CD3ϩCD4-CD8-doublenegative T cells and CD4ϩCD25ϩ regulatory T cell populations in spleens. Anti-CD11c was used to identify DCs, and the activation of CD11c-positive cells was assessed by co-staining for CD40 and MHCII (BD Pharmingen, Heidelberg, Germany). Anti-mouse B220, CD21, CD23, IgD, and IgM antibodies (BD Pharmingen) were used to detect mature B cells . Anti-mouse CD19, CD5, and CD43 were procured from BD Biosciences. Plasma cells were identified using antimouse antibodies for Ig light chain and CD138 (BD Pharmingen). To identify the macrophage population in spleen, we used anti-mouse F4/80, CD11b, MHCII, and CD206 from BD Biosciences. Macrophages (F4/ 80ϩCD11bϩ), M1 macrophages (F4/80ϩCD11bϩMHCIIϩ), and M2 macrophages (F4/80ϩCD11bϩCD206ϩ) were identified as mentioned. Anti-mouse IL17a and IFN␥ (from BD Biosciences) were used along with anti-mouse CD3, CD4, CD8, and NK1.1 antibodies to evaluate Th1, TH17, and NK cells producing IFN␥. Respective isotype antibodies were used to demonstrate specific staining of cell subpopulations. 36 Respective isotype antibodies were used to demonstrate specific staining of cell subpopulations. Quantification of cell number was done using counting beads for FACS (Invitrogen, Carlsbad, CA).
Evaluation of Autoimmune Tissue Injury
Lungs, spleens, livers, lymph nodes, and kidneys from all mice were fixed in 10% buffered formalin, processed, and embedded in paraffin. Sections (2 m) for periodic acid-Schiff stains were prepared following routine protocols. 37 The severity of the renal lesions was graded using the activity and chronicity indices for human lupus nephritis as described. 38 Autoimmune lung injury was scored semiquantitatively (0 to 4) by assessing the extent of peribronchial, perivascular, or interstitial lymphocyte infiltrates as described. 39 For IgM staining of the spleen sections, anti-mouse IgM--chain specific antibodies (Vector, Burlingame, CA) were used.
Complement component C9 antibody (kindly provided from Mohamed R. Daha, University of Leiden, The Netherlands) was used at a 1:50 dilution, and secondary goat anti-rabbit biotinylated antibody (Vector, Burlingame, CA) was used at a 1:300 dilution. Serum cytokine levels were determined by ELISA following the manufacturer's protocols (IL-12p40: OptEiA, BD, Heidelberg, Germany; TNF: BioLegend, San Diego, CA; IL-4: OptEiA, BD, Heidelberg, Germany). Plasma creatinine levels were determined using a commercial assay kit (DiaSys).
Autoantibody Analysis
Serum antibody levels were determined by ELISA as described. 40 For anti-dsDNA antibodies, NUNC maxisorp ELISA plates were coated with poly-Llysine (Trevigen, Gaithersburg, MD) and mouse dsDNA. After incubation with mouse serum, dsDNA-specific IgG and serum IgG and serum IgM levels were detected by ELISA (Bethyl Laboratories, Montgomery, TX). For anti-Smith antibodies, NUNC maxisorp ELISA plates were coated with Smith antigen (Immunovision, Springdale, AR). A horseradish-peroxidase-conjugated goat anti-mouse IgG (Rockland, Gilbertsville, PA) was used for detection. Horseradish-peroxidase-conjugated anti-mouse IgG was used as the secondary antibody. Anti-nuclear antibodies were detected on Hep2 slides (1:50 diluted serum; BioRad Laboratories, Redmond, WA). Sections were mounted with Vectashield containing DAPI (Vector Laboratories, Burlingame, CA).
Real-Time Quantitative (TaqMan) Reverse-Transcriptase PCR Real-time reverse-transcriptase PCR was performed on mRNA from mouse organs as described previously. 33 The SYBR Green Dye detection system was used for quantitative real-time PCR on a Light Cycler 480 (Roche, Mannheim, Germany). All of the technical steps were performed according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines. 41 Controls consisting of double-deionized water were negative for target and housekeeper genes. Gene-specific primers (300 nM, Metabion, Martinsried, Germany) were designed and further analyzed in silico to target all known possible transcripts of interest. Primers are listed in Table 1 .
Statistical Analysis
One-way ANOVA followed by post hoc Bonferroni's test was used for multiple comparisons using GraphPad Prism, version 4.03. Single groups were compared by unpaired two-tailed t test. Data were expressed as mean Ϯ SEM. Statistical significance was assumed at P Ͻ 0.05. 
